1.Optimization of Ultrahigh Pressure Extraction of Forsythoside from Forsythia Suspensa by Box-Behnken Experimental Design
Chenli YE ; Xiayan XU ; Jiang LIU ; Xiaocong WANG ; Weiling CAO
China Pharmacist 2016;19(9):1670-1674
Objective: To optimize the ultrahigh pressure extraction ( UPE) process for forsythoside from Forsythia suspensa by Box-Behnken experimental design. Methods:On the basis of single factor screening, a three-factor and three-level Box-Behnken ex-perimental design was employed with liquid/material ratio( X1 ) , extraction pressure ( X2 ) and extraction time ( X3 ) as the independent variables. The response variable was the extraction yield of forsythoside. Results:The optimal UPE conditions for forsythoside were as follows:the ratio of solvent to material (ml·g-1) was 70, the extraction pressure was 151 MPa, and the extraction time was 114 s. With the optimal extraction process, the extraction yield of forsythoside was 13. 15 mg·g-1 . Conclusion:As a novel extraction tech-nology for Chinese herbal medicines, UPE procedure has higher extraction yield, lower extraction temperature, shorter extraction time and less power consumption, which provides a brand-new method for the extraction of forsythoside from Forsythia suspensa.
2.Clinical Study of Serum Lipoprotein(a) and Homocysteine with Type 2 Diabetes Mellitus and Insulin Resistance
Anyun YU ; Xiayan LIU ; Yu SONG ; Peifang YU
Journal of Modern Laboratory Medicine 2016;31(3):65-68
Objective To analyze the levels of serum lipoprotein (a)[Lp(a)]and homocysteine (CHY)in type 2 diabetes mellitus (T2DM)patients and todetermine the relationship between them and diabetic insulin resistance.Methods A total of 108 patients with T2DM and 50 healthy volunteers (control group)were studied.T2DM group according to the presence of kidney disease complications could be divided into simple diabetes group (SDM)in 48 patients with diabetic nephropathy (DN)group of 60 cases.Collected patients general data and determined two groups of glycosylated hemoglobin (HbA1c), low density lipoprotein (LDL),urea nitrogen (BUN),serum creatinine (SCr),urinary inhibition C (CysC),Lp(a)and HCY levels;Compared differences between groups and how they related to T2DM kidney disease,and the relationship between in-sulin resistance.Results ①Compared between three groups only the weight (NC group 60.1±10.34 kg,SDM group 67.2 ±11.38 kg,DN group 68.8±1.35 kg),the difference was statistically significant (F=0.457,P=0.035).②compared be-tween the three groups,the levels of HbA1c (F=3.421,P=0.013),LDL-C (F=2.963,P=0.041),BUN (F=4.637,P=0.031),SCr (F=2.369,P=0.024),CysC (F=3.697,P=0.011),Lp(a)(F=1.236,P=0.021),HCY (F=4.317,P=0.027)were increased significantly.③FPG,FINS and HOMA-IR in SDM group were 5.99±0.94 mmol/L,61.11±28.46 pmol/L and 2.93±1.97 respectively,FPG,FINS and HOMA-IR in DN group were 9.01±2.23 mmol/L,98.56±62.14 pmol/L and 4.34±2.74 respectively.Compared between the two groups,FPG (t=0.47,P=0.017),FINS (t=0.55,P=0.039),HOMA-IR (t=0.69,P=0.024)differences were statistical significance.④The Lp(a),HCY were significantly pos-itive correlation with HOMA-IR (r=0.761,P=0.044;r=0.840,P=0.021).Conclusion Lp(a)and HCY levels in serum associated with diabetic nephropathy,and insulin resistance.And the detection of serum Lp(a)and HCY has important sig-nificance for early detection of diabetic nephropathy.
3.Clinical Application of RDW,HCY and LP (a) in High Blood Pressure and Combined Coronary Heart Disease
Xiayan LIU ; Anyun YU ; Peifang YU ; Ya WANG
Journal of Modern Laboratory Medicine 2017;32(4):80-82,86
Objective Understanding of red blood cell distribution width (RDW-CV),blood homocysteine (HCY),lipoprotein a [LP(a)] a merger with high blood pressure and high blood,coronary heart disease (CHD) relevance and explore its clinical application value in CHD.Methods 563 cases of patients with high blood pressure were enrolled,which divided into 62 cases of primary hypertension,501 cases of hypertension combined with coronary heart disease,according to the results of coronary angiography.141 normal cases were chosen as control group.Compared the three groups of RDW-CV,HCY and LP (a) level,the group of coronary artery disease was divided into Ⅰ,Ⅱ,Ⅲ and Ⅳ,and compared the RDW-CV level of each group,and the correlation between RDW and cardiac function was analyzed.Results ①Heart disease groups RDW-CV,LP (a) and HCY (13.25 ± 1.22%,17.82 ± 8.36 μmol/L,172.05 ± 122.32 mg/L) were higher than blood pressure groups (12.98 ± 0.57 %,14.35 ± 6.36 μ mol/L,124.49 ± 75.88 mg/L) and normal control group (11.41 ± 2.85 %,11.41 ± 2.85 μmol/L,71.07±27.55 mg/L,P<0.05).②RDW-CV and HCY were positively correlated with the mental function classification (r=0.461,0.1970;P=0.000,0.032).③The area under the ROC curve was the order of the diagnostic value:HCY >LP(a) >RDW-CV.LP(a) sensitivity was 82.5 % and specificity was 31.7 %.RDW-CV sensitivity was 48.8 % and specificity was 22.2 %.Conclusion High levels of RDW-CV,HCY,and LP(a) were closely related to the occurrence of coronary heart disease;RDW-CV and HCY were related to the severity of coronary heart disease and cardiac function,and could be a potential biomarker for the development of cardiac function of coronary heart disease.
4.IT-based management system for rational drug use in medical alliances: development and application
Weiling CAO ; Xiayan XU ; Chenli YE ; Jiang LIU ; Youheng ZHANG
Chinese Journal of Hospital Administration 2019;35(4):335-337
Rational drug use and patient medication safety have always been key to pharmaceutical management.The authors introduced the practice of informationization management of rational drug use in the medical alliance of Luohu Hospital Group.The main measures refer to building an informationization platform for drug purchasing and supply management, dispensing management, medication intervention and medication guidance.This practice can realize closed-loop drug management, achieving full-range supervision and traceability for drugs and higher patient drug use safety.
5.Compliance of antiviral therapy and influencing factors in people living with HIV/AIDS in ;Nanjing
Hongxia WEI ; Meng LI ; Xiayan ZHANG ; Kai BU ; Yibing FENG ; Xiaoyan LIU ; Lingen SHI ; Yuheng CHEN ; Chunqin BAI ; Gengfeng FU ; Xiping HUAN ; Lu WANG
Chinese Journal of Epidemiology 2015;(7):672-676
Objective To understand the compliance of highly active anti-retroviral therapy (HAART) and influencing factors in people living with HIV/AIDS (PLWHA) in Nanjing. Methods PLWHA receiving HAART in No. 2 Hospital of Nanjing during May-June 2014 were recruited in this study. Self-administrated questionnaire was used to collect the data about HAART compliance and socio-demographic characteristics of PLWHA surveyed. Descriptive and multivariate statistical analysis were conducted to examine the effects of the factors on self-reported HAART adherence. Results A total of 276 PLWHA were surveyed,According to the evaluation criterion of Center for Adherence Support Evaluation (CASE),252 cases showed good compliance (91.3%). logistic regression analysis revealed that smoking,progress of the disease and side effects,reminding of taking drug and age were correlated with self-reported HAART adherence. Conclusion It is suggested to strengthen the education about antiviral therapy compliance in PLWHA with mild infection and those who are smokers and young,suffer from side effects,have no reminding methods for taking drug.
6.Application of bronchoscopic lavage in children with severe adenovirus pneumonia
Jie HE ; Xinping ZHANG ; Meiyu YANG ; Xiong ZHOU ; Jianshe CAO ; Zili CAI ; Xiayan KANG ; Bo XIE ; Ying LIU ; Zhenghui XIAO
Chinese Pediatric Emergency Medicine 2021;28(6):472-476
Objective:To investigate the efficacy and safety of bronchoscopic lavage in children with severe adenoviral pneumonia.Methods:Patients with severe adenovirus pneumonia who were admitted to ICU department of Hunan Children′s Hospital for bronchoscopy were collected from February to June 2019 and divided into lavage group( n=36) and non-lavage group( n=15) in line with whether lavage was performed.Their results, namely, bronchoscopic diagnosis, blood gas analysis before and 2 hours, 24 hours and 48 hours after bronchoscopy, improvement time of clinical symptoms(fever and pulmonary moist rales), the positive rate of pathogen detection and mortality rate, main vital signs such as heart rate, respiratory rate, mean arterial pressure and bronchoscopy-related complications were recorded before and 1 hour, 2 hours and 24 hours after bronchoscopy. Results:A total of 51 children were collected, all of whom suffered from endobronchitis.More secretions were observed in the airways of 36 patients in the lavage group, and only a little or no secretions were observed in 15 patients in the non-lavage group.P/F value and PCO 2 at 2 hours, 24 hours and 48 hours after treatment in the lavage group were improved comparing to those before treatment and were superior to those in the non-lavage group( P<0.05). P/F values at 24 hours and 48 hours after treatment in the non-lavage group increased and PCO 2 decreased at 48 hours after treatment( P<0.05). The thermal duration, time to resolution of moist rales in the lungs in the lavage group were shorter than those in the non-lavage group( P<0.05). The mortality rate in the lavage group was lower than that in the non-lavage group[2.8%(1/36) vs.26.7%(4/15), P<0.05]. The positive rate of pathogen detection in lavage group was higher than that in non-lavage group[55.6%(20/36) vs. 20.0%(3/15), P<0.05]. There was no significant difference in heart rate, respiratory rate, and mean arterial pressure at each time point before and after bronchoscopic treatment( P>0.05). Associated complications were 11 cases of intraoperative transient hypoxemia, four cases of bronchial mucosal bleeding, and one case each of postoperative hypoxemia, intraoperative hypertension and hypotension.There was no significant difference in the incidence of complications between the two groups( P>0.05). Conclusion:Bronchoscopic lavage, in treating children with severe adenovirus pneumonia, may improve clinical symptoms, respiratory function, and rate of pathogen detection, reduce mortality, and is effective and safe.
7.Study on economic burden caused by antiretroviral treatment for people living with HIV/AIDS and influencing factors in Nanjing.
Xiayan ZHANG ; Meng LI ; Yibing FENG ; Kai BU ; Gengfeng FU ; Xiaoyan LIU ; Yuheng CHEN ; Lingen SHI ; Chunqin BAI ; Hongxia WEI ; Xiping HUAN ; Email: HUANXIP@VIP.SINA.COM. ; Lu WANG ; Email: WANGLU64@163.COM.
Chinese Journal of Epidemiology 2015;36(5):440-444
OBJECTIVETo understand the economic burden caused by antiretroviral treatment for people living with HIV/AIDS and influencing factors in Nanjing.
METHODSPeople living with HIV/AIDS were divided into two groups, HIV infected patients and AIDS patients. The data about their direct medical expenditure, direct non-medical expenditure and indirect economic loss in the past year were collected. Univariate and multivariate analysis were conducted to identify the potential influencing factors.
RESULTSThe median of direct medical expenditure and total costs for 133 HIV infected patients were 1,200 yuan RMB and 1,972 yuan RMB respectively. The median of direct medical expenditure and total costs for 145 AIDS patients were 1 060 yuan RMB and 2 826 yuan RMB respectively. The differences in direct medical expenditure and total costs between HIV infected patients and AIDS patients showed no statistical significance. The results from univariate analysis indicated that the sample source influenced total costs significantly. Multivariate analysis showed that onset time and CD level were negatively correlated with direct medical expenditure. The patients infected through heterosexual contact had more direct medical expenditure than those infected through homosexual contact. The patients receiving HIV test in hospitals had more direct medical expenditure than those receiving volunteer counseling and testing.
CONCLUSIONFurther efforts should be made to expand HIV testing and treatment coverage in order to detect HIV infections as early as possible. Early antiretroviral treatment should be given to HIV infected patients to maintain their immunity and reduce their medical expenditure.
Acquired Immunodeficiency Syndrome ; drug therapy ; economics ; Anti-Retroviral Agents ; economics ; therapeutic use ; China ; Cost of Illness ; Counseling ; HIV Infections ; drug therapy ; economics ; Health Expenditures ; statistics & numerical data ; Heterosexuality ; Humans ; Mass Screening ; Voluntary Programs
8.Drop out of antiretroviral therapy in people living with AIDS/HIV and related factors in Nanjing and Yuncheng.
Meng LI ; Hongxia WEI ; Kai BU ; Xiaoyan LIU ; Yibing FENG ; Lingen SHI ; Xiayan ZHANG ; Yuheng CHEN ; Fangfang CHEN ; Xiaomin LI ; Gengfeng FU ; Xiping HUAN ; Lu WANG ; Email: WANGLU64@163.COM.
Chinese Journal of Epidemiology 2015;36(10):1113-1118
OBJECTIVETo understand the incidence of drop out of antiretroviral therapy (ART) in people living with AIDS/HIV and related factors in Nanjing, Jiangsu province, and Yuncheng, Shanxi province.
METHODSRetrospective cohort analysis was conducted. The cumulative incidence curves of drop out of ART, mortality and drug withdrawal were drawn with Kaplan-Meier method. The related factors were identified with Cox proportional hazards regression model.
RESULTSA total of 1 006 patients were included in Yuncheng, the median length of ART follow-up was 49.59 months (QR: 20.02-92.84), and 976 patients were included in Nanjing, the median length of ART follow-up was 19.93 months (QR: 11.48-34.07). The cumulative incidence of drop out of ART at 3 months, 6 months, 1 year, 2 years, 4 years, 8 years after ART was 8.19%, 9.23%, 11.08%, 13.75%, 17.74%, 27.66% in Yuncheng, and 3.01%, 5.17%, 7.47%, 10.97%, 17.45%, 28.72% in Nanjing respectively. Age, marital status, infection route, baseline CD4 cell count, the clinical stage classified by WHO at the end of the observation were correlated with the drop out of ART.
CONCLUSIONIn order to reduce the drop out of ART among people living with AIDS/HIV, it is necessary to conduct effective interventions targeting the patients with young age, the patients who divorced/widowed, the patients who were intravenous drug users, the patients with higher CD4 cell count at the beginning of ART and clinical stage III or IV at the end of the follow-up and increase the coverage of HIV test.
Acquired Immunodeficiency Syndrome ; drug therapy ; Anti-Retroviral Agents ; administration & dosage ; CD4 Lymphocyte Count ; China ; Communicable Diseases ; Humans ; Incidence ; Medication Adherence ; Proportional Hazards Models ; Retrospective Studies
9.Compliance of antiviral therapy and influencing factors in people living with HIV/AIDS in Nanjing.
Hongxia WEI ; Meng LI ; Xiayan ZHANG ; Kai BU ; Yibing FENG ; Xiaoyan LIU ; Ling'en SHI ; Yuheng CHEN ; Chunqin BAI ; Gengfeng FU ; Xiping HUAN ; Email: HUANXP@VIP.SINA.COM. ; Lu WANG ; Email: WANGLU64@163.COM.
Chinese Journal of Epidemiology 2015;36(7):672-676
OBJECTIVETo understand the compliance of highly active anti-retroviral therapy (HAART) and influencing factors in people living with HIV/AIDS (PLWHA) in Nanjing.
METHODSPLWHA receiving HAART in No. 2 Hospital of Nanjing during May-June 2014 were recruited in this study. Self-administrated questionnaire was used to collect the data about HAART compliance and socio-demographic characteristics of PLWHA surveyed. Descriptive and multivariate statistical analysis were conducted to examine the effects of the factors on self-reported HAART adherence.
RESULTSA total of 276 PLWHA were surveyed, According to the evaluation criterion of Center for Adherence Support Evaluation (CASE), 252 cases showed good compliance (91.3%). logistic regression analysis revealed that smoking, progress of the disease and side effects, reminding of taking drug and age were correlated with self-reported HAART adherence.
CONCLUSIONIt is suggested to strengthen the education about antiviral therapy compliance in PLWHA with mild infection and those who are smokers and young, suffer from side effects, have no reminding methods for taking drug.
Acquired Immunodeficiency Syndrome ; drug therapy ; Age Factors ; Antiretroviral Therapy, Highly Active ; Antiviral Agents ; adverse effects ; therapeutic use ; China ; Disease Progression ; HIV Infections ; drug therapy ; Humans ; Medication Adherence ; statistics & numerical data ; Reminder Systems ; Smoking ; Surveys and Questionnaires